By Robert PreidtHealthDay Reporter MONDAY, Dec. 28, 2020 (HealthDay News) — Hospitalized COVID-19 patients with brain complications such as stroke and confusion have an increased risk of death, a new study shows. The findings could improve care and save lives during the pandemic, the researchers said. “This study is the first to … Read more
For its Solidarity clinical trial, the WHO tested the effects four potential treatments – remdesivir, an Ebola drug, was one, but they also looked at malaria drug hydroxychloroquine, auto-immune drug interferon, and the HIV drug combination of lopinavir and ritonavir. Source link
THURSDAY, Oct. 1, 2020 (HealthDay News) — Revealing some good news for minorities, a new study found similar survival rates for Hispanic, Black and white COVID-19 patients at a New York City hospital system. “It is well-documented that communities of color have shouldered the heaviest burden of COVID-19 in the United States, and there … Read more
By E.J. Mundell HealthDay Reporter MONDAY, Aug. 24, 2020 (HealthDay News) — In the largest such study yet, researchers have found that two classes of common blood pressure medications seem tied to better survival against COVID-19. The U.K. findings should allay any worry that the two types of mediations — angiotensin-converting enzyme inhibitors (ACE inhibitors) … Read more